Vimarsana
Biggest News Aggregation in the World

Aptamer Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptamer Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptamer Sciences Today - Breaking & Trending Today

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs - Vimarsana News

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs

Published: March 26, 2024

/PRNewswire/ -- Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of...

Source: prnewswire.com
Related Topics:
Kyonggi DoSouth KoreaHong Jae ChonAprc Aptamer RadioligandNational Cancer CenterAptamer Sciences IncBundang Medical CenterSamsung Medical CenterKorean Ministry Of FoodAptamer SciencesInvestigational New DrugKorean MinistryDrug SafetyAptamer Drug ConjugateEast AsiaNature MedicineMedical CenterSeverance HospitalAptamer Radioligand ConjugateAptamer Immune Stimulator ConjugateDong Il HanSciences IncAptamer Sciences Inc
Aptamers Market to Reach US$ 5.4 Billion by 2027, Impelled by Increasing Usage in Drug Discovery - Vimarsana News

Aptamers Market to Reach US$ 5.4 Billion by 2027, Impelled by Increasing Usage in Drug Discovery

Published: November 16, 2022

Global Aptamers Market Impelled by Increasing Usage in Drug Discovery

Source: einnews.com
Related Topics:
United StatesAptamers Market Companies AnalysisPair Biotechnologies IncVivonics IncSomalogic IncKaneka Eurogentec Sa CorporationTrilink BiotechnologiesAptamer Sciences IncAptamer GroupNeoventures Biotechnology IncAptamers Market SizeAptamers Market ImpelledIncreasing UsageGlobal Industry TrendsKey PlayersMarket Companies AnalysisAptamer SciencesBase Pair BiotechnologiesKaneka CorporationNeoventures BiotechnologyMarket SegmentationMiddle EastExplore Full Report WithMarket PerformanceMarket Outlook
Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™

Published: March 4, 2022

Aptamers Market worth $342 million by 2026 – Exclusive Report by MarketsandMarkets™

Source: sandiegosun.com
Related Topics:
United StatesSouth KoreaAsia PacificAashish MehraRaptamer Discovery GroupSomalogic IncResearch NewswireEnd Users Pharmaceutical Biotechnology CompaniesSee CampaignAptamer Sciences IncAptamer Group United KingdomAcademic Government Research InstitutesMarketby Product TypeEnd UsersBiotechnology CompaniesGovernment Research InstitutesNorth AmericaLatin AmericaMiddle EastSample PagesAptamer GroupUnited KingdomAptamer SciencesFinancial ContentExtended Distribution
Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™

Published: March 4, 2022

Aptamers Market worth $342 million by 2026 – Exclusive Report by MarketsandMarkets™

Source: texasguardian.com
Related Topics:
United StatesSouth KoreaAsia PacificAashish MehraRaptamer Discovery GroupSomalogic IncResearch NewswireEnd Users Pharmaceutical Biotechnology CompaniesSee CampaignAptamer Sciences IncAptamer Group United KingdomAcademic Government Research InstitutesMarketby Product TypeEnd UsersBiotechnology CompaniesGovernment Research InstitutesNorth AmericaLatin AmericaMiddle EastSample PagesAptamer GroupUnited KingdomAptamer SciencesFinancial ContentExtended Distribution
Aptamers Market is anticipated to grow at a CAGR of 17.03% from 2021 to 2027 globally - Vimarsana News

Aptamers Market is anticipated to grow at a CAGR of 17.03% from 2021 to 2027 globally

Published: January 14, 2022

Aptamers Market is anticipated to grow at a CAGR of 17.03% from 2021 to 2027 globally – Axiom MRC

Source: sandiegosun.com
Related Topics:
New YorkUnited StatesAsia PacificOphthotech CorporationAxiom Market Research ConsultingGlobal ClientVivonics IncSomalogic IncMarket ResearchResearch NewswireSee CampaignAptamer Sciences IncPair BiotechnologiesResearch Objectives Of Aptamers MarketAxiom Market ResearchNorth AmericaAptamer SciencesBase Pair BiotechnologiesTrilink BiotechnologiesAptamers Market ReportPeptides MarketFeeding Formulas MarketMarket Research ProjectsData Analytics ProjectsBusiness Support Projects